UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites

Endocrinology (Philadelphia), 2004-11, Vol.145 (11), p.4997-5005

2004

Volltextzugriff (PDF)

The C-terminal Nonapeptide of Mature Chemerin Activates the Chemerin Receptor with Low Nanomolar Potency

The Journal of biological chemistry, 2004-03, Vol.279 (11), p.9956-9962

2004

Volltextzugriff (PDF)

Desensitization of the human motilin receptor by motilides

The Journal of pharmacology and experimental therapeutics, 2005-06, Vol.313 (3), p.1397-1405

2005

Volltextzugriff (PDF)

Identification and characterization of an endogenous chemotactic ligand specific for FPRL2

The Journal of experimental medicine, 2005-01, Vol.201 (1), p.83-93

2005

Volltextzugriff (PDF)

Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation

Endocrinology (Philadelphia), 2005-03, Vol.146 (3), p.1514-1522

2005

Volltextzugriff (PDF)

Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum

The Journal of pharmacology and experimental therapeutics, 2003-05, Vol.305 (2), p.660-667

2003

Volltextzugriff (PDF)

Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction

The Journal of biological chemistry, 2001-01, Vol.276 (2), p.1084-1088

2001

Volltextzugriff (PDF)

Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine

British journal of pharmacology, 2005-04, Vol.144 (7), p.994-1001

2005

Volltextzugriff (PDF)

Evidence for a Direct and Functional Interaction between the Regulators of G Protein Signaling-2 and Phosphorylated C Terminus of Cholecystokinin-2 Receptor

Molecular pharmacology, 2009-03, Vol.75 (3), p.502-513

2009

Volltextzugriff (PDF)

Contribution of the Carboxyl Terminus of the VPAC1 Receptor to Agonist-induced Receptor Phosphorylation, Internalization, and Recycling

The Journal of biological chemistry, 2005-07, Vol.280 (30), p.28034-28043

2005

Volltextzugriff (PDF)

Inhibitory pathways in the circular muscle of rat jejunum

British journal of pharmacology, 2004-09, Vol.143 (1), p.107-118

2004

Volltextzugriff (PDF)

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

Peptides (New York, N.Y. : 1980), 1997, Vol.18 (10), p.1555-1560

1997

Volltextzugriff (PDF)

Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor

Journal of molecular endocrinology, 2005-04, Vol.34 (2), p.405-414

2005

Volltextzugriff (PDF)

Development of high affinity selective VIP1 receptor agonists

Peptides (New York, N.Y. : 1980), 1997, Vol.18 (10), p.1539-1545

1997

Volltextzugriff (PDF)

Localization of transforming growth factor β1 and its latent binding protein in human chronic pancreatitis

Gastroenterology (New York, N.Y. 1943), 1995-06, Vol.108 (6), p.1873-1881

1995

Volltextzugriff (PDF)

Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives

The Journal of pharmacology and experimental therapeutics, 1999-03, Vol.288 (3), p.1207

1999

Volltextzugriff (PDF)

Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain

Peptides (New York, N.Y. : 1980), 1997, Vol.18 (10), p.1547-1554

1997

Volltextzugriff (PDF)

Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation

Cellular signalling, 2005-01, Vol.17 (1), p.17-24

2005

Volltextzugriff (PDF)

Involvement of Pituitary Adenylate Cyclase‐Activating Polypeptide II Vasoactive Intestinal Peptide 2 Receptor in Mouse Neocortical Astrocytogenesis

Journal of neurochemistry, 1998-05, Vol.70 (5), p.2165-2173

1998

Volltextzugriff (PDF)

Influence of selective VIP receptor agonists in the rat gastric fundus

European journal of pharmacology, 1998-10, Vol.359 (1), p.77-80

1998

Volltextzugriff (PDF)

Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC2-Selective Ligands

Molecular pharmacology, 1999-12, Vol.56 (6), p.1280

1999

Volltextzugriff (PDF)

Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain

Annals of the New York Academy of Sciences, 1998-12, Vol.865 (1), p.412-415

1998

Volltextzugriff (PDF)

VIP and PACAP 38 Modulate Ibotenate-Induced Neuronal Heterotopias in the Newborn Hamster Neocortex

Journal of neuropathology and experimental neurology, 2000-12, Vol.59 (12), p.1051-1062

2000

Volltextzugriff (PDF)

International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide

Pharmacological reviews, 1998-06, Vol.50 (2), p.265

1998

Volltextzugriff (PDF)

Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)

British journal of pharmacology, 2006-08, Vol.148 (8), p.1051-1059

2006

Volltextzugriff (PDF)

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(268)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Englisch
(276)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Animals
(160)
Life Sciences & Biomedicine
(158)
Rats
(94)
Biological And Medical Sciences
(92)
Adenylyl Cyclases - Metabolism
(91)
Humans
(88)
Male
(69)
Biochemistry & Molecular Biology
(65)
Fundamental And Applied Biological Sciences. Psychology
(65)
Molecular Sequence Data
(54)
Amino Acid Sequence
(53)
Vasoactive Intestinal Peptide - Pharmacology
(52)
Vasoactive Intestinal Peptide - Metabolism
(45)
Pharmacology & Pharmacy
(44)
Adenylate Cyclase
(42)
Cricetinae
(42)
Cho Cells
(37)
Pituitary Adenylate Cyclase-Activating Polypeptide
(36)
Female
(35)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ghrelin Degradation by Serum and Tissue Homogenates: Identification of the Cleavage Sites

The C-terminal Nonapeptide of Mature Chemerin Activates the Chemerin Receptor with Low Nanomolar Potency

Desensitization of the human motilin receptor by motilides

Identification and characterization of an endogenous chemotactic ligand specific for FPRL2

Ghrelin Is Produced by the Human Erythroleukemic HEL Cell Line and Involved in an Autocrine Pathway Leading to Cell Proliferation

Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum

Two Basic Residues of the h-VPAC1 Receptor Second Transmembrane Helix Are Essential for Ligand Binding and Signal Transduction

Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine

Evidence for a Direct and Functional Interaction between the Regulators of G Protein Signaling-2 and Phosphorylated C Terminus of Cholecystokinin-2 Receptor

Contribution of the Carboxyl Terminus of the VPAC1 Receptor to Agonist-induced Receptor Phosphorylation, Internalization, and Recycling

Inhibitory pathways in the circular muscle of rat jejunum

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor

Development of high affinity selective VIP1 receptor agonists

Localization of transforming growth factor β1 and its latent binding protein in human chronic pancreatitis

Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives

Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain

Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation

Involvement of Pituitary Adenylate Cyclase‐Activating Polypeptide II Vasoactive Intestinal Peptide 2 Receptor in Mouse Neocortical Astrocytogenesis

Influence of selective VIP receptor agonists in the rat gastric fundus

Different Vasoactive Intestinal Polypeptide Receptor Domains Are Involved in the Selective Recognition of Two VPAC2-Selective Ligands

Autoradiographic Visualization of the Receptor Subclasses for Vasoactive Intestinal Polypeptide (VIP) in Rat Brain

VIP and PACAP 38 Modulate Ibotenate-Induced Neuronal Heterotopias in the Newborn Hamster Neocortex

International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide

Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2)

Suchergebnisse filtern